1887

Abstract

Replicating viruses generally induce type 1 immune responses, with high interferon (IFN)- levels and antibodies of the IgG2a isotype. In the present study we demonstrate the intrinsic ability of non-replicating virions to induce comparable immune responses in the notable absence of any adjuvant. Injection of inactivated pseudorabies virus, an alphaherpesvirus, by various routes into mice resulted in the generation of T helper (Th) 1 type immune response. Co-delivery of inactivated pseudorabies herpesvirus (iPRV) with protein redirected IgG1-dominated tetanus toxoid-specific responses towards an IgG1/IgG2a balanced response. Also inactivated preparations of viruses from the paramyxo- (Newcastle disease virus), rhabdo- (rabies virus), corona- (infectious bronchitis virus) and reovirus (avian reovirus) families led to IgG2a antibody responses; however, the genetic background of the host did result in considerable variation. Because disrupted virions also induced type 1 immune responses, we conclude that structural elements of virions inherently contribute to IFN--dependent isotype switching by inactivated viruses. Strikingly, immunizations in gene-disrupted mice showed that a functional IFN-/, IFN- or interleukin (IL)-12 pathway was not required for the generation of a polarized Th1 type immune response initiated by inactivated virus particles. These findings have a bearing on the understanding of immune responsiveness to virus structures and the design of vaccines containing virus components.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19605-0
2004-04-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/4/vir850795.html?itemId=/content/journal/jgv/10.1099/vir.0.19605-0&mimeType=html&fmt=ahah

References

  1. Bachmann M. F., Kopf M. 1999; The role of B cells in acute and chronic infections. Curr Opin Immunol 11:332–339
    [Google Scholar]
  2. Bachmann M. F., Kalinke U., Althage A., Freer G., Burkhart C., Roost H., Aguet M., Hengartner H., Zinkernagel R. M. 1997; The role of antibody concentration and avidity in antivirus protection. Science 276:2024–2027
    [Google Scholar]
  3. Balkovic E. S., Florack J. A., Six H. R. 1987; Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different forms. Antiviral Res 8:151–160
    [Google Scholar]
  4. Brett S. J., Dunlop L., Liew F. Y., Tite J. P. 1993; Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza A nucleoprotein. Immunology 80:306–312
    [Google Scholar]
  5. Cavanagh D. 1983; Coronavirus IBV: further evidence that the surface projections are associated with two glycopolypeptides. J Gen Virol 64:1787–1791
    [Google Scholar]
  6. Coffman R. L., Ohara J., Bond M. W., Carty J., Zlotnik A., Paul W. E. 1986; B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 136:4538–4541
    [Google Scholar]
  7. Coffman R. L., Varkila K., Scott P., Chatelain R. 1991; Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev 123:189–207
    [Google Scholar]
  8. Consales C. A., Valentini J. G., Albas A., Mendonca R. M., Fuches R. M., Soares M. A., Pereira C. A. 1988; The preparation of cultured rabies virus and the production of antiserum for human use. J Biol Stand 16:27–32
    [Google Scholar]
  9. Cousens L. P., Orange J. S., Su H. C., Biron C. A. 1997; Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A 94:634–639
    [Google Scholar]
  10. Coutelier J. P., van der Logt J. T., Heessen F. W., Warnier G., Van Snick J. 1987; IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 165:64–69
    [Google Scholar]
  11. Coutelier J. P., van der Logt J. T., Heessen F. W., Vink A., Van Snick J. 1988; Virally induced modulation of murine IgG antibody subclasses. J Exp Med 168:2373–2378
    [Google Scholar]
  12. Fehr T., Bachmann M. F., Bluethmann H., Kikutani H., Hengartner H., Zinkernagel R. M. 1996; T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. Cell Immunol 168:184–192
    [Google Scholar]
  13. Finkelman F. D., Svetic A., Gresser I., Snapper C., Holmes J., Trotta P. P., Katona I. M., Gause W. C. 1991; Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med 174:1179–1188
    [Google Scholar]
  14. Grob P., Schijns V. E., van den Broek M. F., Cox S. P., Ackermann M., Suter M. 1999; Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection. J Virol 73:4748–4754
    [Google Scholar]
  15. Haynes L. M., Moore D. D., Kurt-Jones E. A., Finberg R. W., Anderson L. J., Tripp R. A. 2001; Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75:10730–10737
    [Google Scholar]
  16. Hocart M. J., Mackenzie J. S., Stewart G. A. 1989; The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies. J Gen Virol 70:2439–2448
    [Google Scholar]
  17. Hochrein H., Shortman K., Vremic D., Scott B., Hertzog P., O'Keeffe M. 2001; Differential production of IL-12, IFN- α and IFN- γ by mouse dendritic cell subsets. J Immunol 166:5448–5455
    [Google Scholar]
  18. Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. 1993; Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547–549
    [Google Scholar]
  19. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R. M., Aguet M. 1993; Immune response in mice that lack the interferon-gamma receptor. Science 259:1742–1745
    [Google Scholar]
  20. Isaacs A., Lindenman J. 1957; Virus interference. II: Some properties of interferon. Proc R Soc 147:268–273
    [Google Scholar]
  21. Jankovic D., Kullberg M. C., Hieny M., Caspar P., Collazo C. M., Sher A. 2002; In the absence of IL-12, CD4+ T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10−/− setting. Immunity 16:429–439
    [Google Scholar]
  22. Katayama S., Oda K., Ohgitani T., Hirahara T., Shimizu Y. 1999; Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice. Vaccine 17:2733–2739
    [Google Scholar]
  23. Katz D., Lehrer S., Galan O., Lachmi B. E., Cohen S. 1991; Adjuvant effects of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody, antibody-isotype and delayed-type hypersensitivity responses to Semliki Forest virus in mice. FEMS Microbiol Immunol 3:305–320
    [Google Scholar]
  24. Kipps T. J., Parham P., Punt J., Herzenberg L. A. 1985; Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med 161:1–17
    [Google Scholar]
  25. Kurt-Jones E. A., Popova L., Kwinn L. 8 other authors 2000; Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398–401
    [Google Scholar]
  26. Lafon M., Lafage M., Martinez-Arends A., Ramirez R., Vuillier F., Charron D., Lotteau V., Scott-Algara D. 1992; Evidence for a viral superantigen in humans. Nature 358:507–510
    [Google Scholar]
  27. Magram J., Connaughton S. E., Warrier R. R. 7 other authors 1996; IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471–481
    [Google Scholar]
  28. Markine-Goriaynoff D., van der Logt J. T., Truyens C., Nguyen T. D., Heessen F. W., Bigaignon G., Carlier Y., Coutelier J. P. 2000; IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. Int Immunol 12:223–230
    [Google Scholar]
  29. Milone M. C., Fitzgerald-Bocarsly P. 1998; The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses. J Immunol 161:2391–2399
    [Google Scholar]
  30. Monteyne P., Van Broeck J., Van Snick J., Coutelier J. P. 1993; Inhibition by lactate dehydrogenase-elevating virus of in vivo interleukin 4 production during immunization with keyhole limpet haemocyanin. Cytokine 5:394–397
    [Google Scholar]
  31. Muller U., Steinhoff U., Reis L. F., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. 1994; Functional role of type I and type II interferons in antiviral defense. Science 264:1918–1921
    [Google Scholar]
  32. Nguyen K. B., Watford W. T., Salomon R., Hofmann S. R., Pien G. C., Morinobu A., Gadina M., O'Shea J. J., Biron C. A. 2002; Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297:2063–2066
    [Google Scholar]
  33. Ochsenbein A. F., Pinschewer D. D., Odermatt B., Ciurea A., Hengartner H., Zinkernagel R. M. 2000; Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design. J Immunol 164:6296–6302
    [Google Scholar]
  34. Okamura H., Tsutsi H., Komatsu T. other authors 1995; Cloning of a new cytokine that induces IFN- γ production by T cells. Nature 378:88–91
    [Google Scholar]
  35. Oppmann B., Lesley R., Blom B. 22 other authors 2000; Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715–725
    [Google Scholar]
  36. Oxenius A., Karrer U., Zinkernagel R. M., Hengartner H. 1999; IL-12 is not required for induction of type 1 cytokine responses in viral infections. J Immunol 162:965–973
    [Google Scholar]
  37. Pflanz S., Timans J. C., Cheung J. 18 other authors 2002; IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16:779–790
    [Google Scholar]
  38. Quint W., Gielkens A., van Oirschot J., Berns A., Cuypers H. T. 1987; Construction and characterization of deletion mutants of pseudorabies virus: a new generation of ‘live’ vaccines. J Gen Virol 68:523–534
    [Google Scholar]
  39. Raj N. B., Cheung S. C., Rosztoczy I., Pitha P. M. 1992; Mouse genotype affects inducible expression of cytokine genes. J Immunol 148:1934–1940
    [Google Scholar]
  40. Rogers P. R., Croft M. 1999; Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance. J Immunol 163:1205–1213
    [Google Scholar]
  41. Rogge L., D'Ambrosio D., Biffi M., Penna G., Minetti L. J., Presky D. H., Adorini L., Sinigaglia F. 1998; The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol6567–6574
    [Google Scholar]
  42. Romer-Oberdorfer A., Mundt E., Mebatsion T., Buchholz U. J., Mettenleiter T. C. 1999; Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 80:2987–2995
    [Google Scholar]
  43. Rosenberger J. K., Sterner F. J., Botts S., Lee K. P., Margolin A. 1989; In vitro and in vivo characterization of avian reoviruses. I. Pathogenicity and antigenic relatedness of several avian reovirus isolates. Avian Dis 33:535–544
    [Google Scholar]
  44. Samuel C. E. 2001; Antiviral actions of interferons. Clin Microbiol Rev 14:778–809
    [Google Scholar]
  45. Schijns V. E., Haagmans B. L., Rijke E. O., Huang S., Aguet M., Horzinek M. C. 1994; IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J Immunol 153:2029–2037
    [Google Scholar]
  46. Schijns V. E., Haagmans B. L., Wierda C. M., Kruithof B., Heijnen I. A., Alber G., Horzinek M. C. 1998; Mice lacking IL-12 develop polarized Th1 cells during viral infection. J Immunol 160:3958–3964
    [Google Scholar]
  47. Snapper C. M., Paul W. E. 1987; Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944–947
    [Google Scholar]
  48. Spiegelberg H. L. 1974; Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol 19:259–294
    [Google Scholar]
  49. Suzuki K., Mori A., Ishii K. J., Saito J., Singer D. S., Klinman D. M., Krause P. R., Kohn L. D. 1999; Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A 96:2285–2290
    [Google Scholar]
  50. Szomolanyi-Tsuda E., Welsh R. M. 1996; T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med 183:403–411
    [Google Scholar]
  51. van den Broek M. F., Muller U., Huang S., Aguet M., Zinkernagel R. M. 1995; Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 69:4792–4796
    [Google Scholar]
  52. Visser N., Lütticken D. 1989; Experiences with a gI-/TK- modified live pseudorabies virus vaccine: strain Begonia. In Vaccinatation and Control of Aujeszky's Disease pp  37–44 Edited by T J. Van Oirschot:
    [Google Scholar]
  53. Wenner C. A., Guler M. L., Macatonia S. E., O'Garra A., Murphy K. M. 1996; Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol 156:1442–1447
    [Google Scholar]
  54. Xing Z., Zganiacz A., Wang J., Divangahi M., Nawaz F. 2000; IL-12 independent Th1-type immune responses to respiratory viral infection: requirement of IL-18 for IFN- γ release in the lung but not for differentiation of viral-reactive Th1-type lymphocytes. J Immunol 164:2575–2584
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19605-0
Loading
/content/journal/jgv/10.1099/vir.0.19605-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error